We work to improve regional surveillance and laboratory capacity for early detection and genetic sequencing of disease threats. The Asia Pathogen Genomics Initiative supports countries across the region in early detection and variant
analysis through enhanced genomic surveillance and data sharing.
We translate basic science innovations into new tools and technologies to diagnose, treat and prevent emerging diseases. This includes early isolation and swift characterization of pathogen threats, the development of viral neutralization tests, and cutting-edge efforts to investigate potential treatments and vaccines. We also support multi-country platforms for clinical trial research.
We support health system improvements through information, innovation and capacity strengthening. This includes predictive modelling of outbreaks, leadership development and cross-country learning exchanges to advance best-practice models of care.
We foster an enabling environment for health security through better policies, legal frameworks, financing and regulatory systems. This includes strategic planning, investment-case development, strategies to balance intellectual property rights in the context of public health emergencies, and efforts to accelerate the convergence of regulatory requirements across countries in the region.